Inhibitor Prevention is Possible With Using Plasma-Derived Fviii Products in Pup Patients: one Center Experience

Kavaklı, K.Karadas, N.Balkan, C.2024-08-252024-08-2520231351-82161365-2516https://hdl.handle.net/11454/101668[No abstract available]eninfo:eu-repo/semantics/closedAccessInhibitor Prevention is Possible With Using Plasma-Derived Fviii Products in Pup Patients: one Center ExperienceConference Object292626WOS:001088127600028Q2